Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

OBIO

+ Watchlist+ Portfolio

Orchestra BioMed Holdings, Inc.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$6.97
52-Week Range
$3.46 – $7.83
Market Cap
$587.14M
P/E (TTM)
—
EPS (TTM)
-0.75
Dividend Yield
0.00%
Advanced Metrics
Price/Book
58.74
PEG Ratio
—
Return on Equity
-182.29%
Return on Assets
-35.86%
Gross Margin
99.56%
Operating Margin
-195.39%
Profit Margin
-182.50%
Current Ratio
7.25
Debt/Equity
3.92
Total Debt
$73.54M
Free Cash Flow
$-37.93M
Revenue Growth
-89.40%
Earnings Growth
—
Enterprise Value
$569.74M

Market Snapshot

About

Orchestra BioMed Holdings, Inc. develops biomedical innovations focused on treating cardiovascular and vascular diseases with novel medical devices and therapies.